A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome
Identifieur interne : 001476 ( Main/Exploration ); précédent : 001475; suivant : 001477A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome
Auteurs : Roger Kurlan [États-Unis] ; Giovanna Crespi [États-Unis] ; Barbara Coffey [États-Unis] ; Kirsten Mueller-Vahl [Allemagne] ; Stephen Koval [États-Unis] ; Glen Wunderlich [Canada]Source :
- Movement Disorders [ 0885-3185 ] ; 2012-05.
English descriptors
Abstract
Dopamine agonists could theoretically normalize the suspected central dopamine hypersensitivity in Tourette's syndrome.
Url:
DOI: 10.1002/mds.24919
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000D72
- to stream Istex, to step Curation: 000D72
- to stream Istex, to step Checkpoint: 000323
- to stream Main, to step Merge: 001508
- to stream Main, to step Curation: 001476
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome</title><author><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name></author><author><name sortKey="Crespi, Giovanna" sort="Crespi, Giovanna" uniqKey="Crespi G" first="Giovanna" last="Crespi">Giovanna Crespi</name></author><author><name sortKey="Coffey, Barbara" sort="Coffey, Barbara" uniqKey="Coffey B" first="Barbara" last="Coffey">Barbara Coffey</name></author><author><name sortKey="Mueller Ahl, Kirsten" sort="Mueller Ahl, Kirsten" uniqKey="Mueller Ahl K" first="Kirsten" last="Mueller-Vahl">Kirsten Mueller-Vahl</name></author><author><name sortKey="Koval, Stephen" sort="Koval, Stephen" uniqKey="Koval S" first="Stephen" last="Koval">Stephen Koval</name></author><author><name sortKey="Wunderlich, Glen" sort="Wunderlich, Glen" uniqKey="Wunderlich G" first="Glen" last="Wunderlich">Glen Wunderlich</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:563328031B9EB7FF732D960D9842281AACFC3197</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1002/mds.24919</idno><idno type="url">https://api-v5.istex.fr/document/563328031B9EB7FF732D960D9842281AACFC3197/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000D72</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000D72</idno><idno type="wicri:Area/Istex/Curation">000D72</idno><idno type="wicri:Area/Istex/Checkpoint">000323</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000323</idno><idno type="wicri:doubleKey">0885-3185:2012:Kurlan R:a:multicenter:randomized</idno><idno type="wicri:Area/Main/Merge">001508</idno><idno type="wicri:Area/Main/Curation">001476</idno><idno type="wicri:Area/Main/Exploration">001476</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome</title><author><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Atlantic Neuroscience Institute, Overlook Hospital, Summit, New Jersey</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Atlantic Neuroscience Institute, Overlook Hospital, 99 Beauvoir Ave., Summit, NJ 07902</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation></author><author><name sortKey="Crespi, Giovanna" sort="Crespi, Giovanna" uniqKey="Crespi G" first="Giovanna" last="Crespi">Giovanna Crespi</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Coffey, Barbara" sort="Coffey, Barbara" uniqKey="Coffey B" first="Barbara" last="Coffey">Barbara Coffey</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Nathan Kline Institute for Psychiatric Research, Orangeburg, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Mueller Ahl, Kirsten" sort="Mueller Ahl, Kirsten" uniqKey="Mueller Ahl K" first="Kirsten" last="Mueller-Vahl">Kirsten Mueller-Vahl</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover</wicri:regionArea><placeName><region type="land" nuts="2">Basse-Saxe</region><settlement type="city">Hanovre</settlement></placeName></affiliation></author><author><name sortKey="Koval, Stephen" sort="Koval, Stephen" uniqKey="Koval S" first="Stephen" last="Koval">Stephen Koval</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Wunderlich, Glen" sort="Wunderlich, Glen" uniqKey="Wunderlich G" first="Glen" last="Wunderlich">Glen Wunderlich</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2012-05">2012-05</date><biblScope unit="volume">27</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="775">775</biblScope><biblScope unit="page" to="778">778</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">563328031B9EB7FF732D960D9842281AACFC3197</idno><idno type="DOI">10.1002/mds.24919</idno><idno type="ArticleID">MDS24919</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Tourette's syndrome</term><term>dopamine agonist</term><term>pramipexole</term><term>tics</term><term>treatment, clinical trial</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Dopamine agonists could theoretically normalize the suspected central dopamine hypersensitivity in Tourette's syndrome.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Canada</li><li>États-Unis</li></country><region><li>Basse-Saxe</li><li>Connecticut</li><li>New Jersey</li><li>État de New York</li></region><settlement><li>Hanovre</li></settlement></list><tree><country name="États-Unis"><region name="New Jersey"><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name></region><name sortKey="Coffey, Barbara" sort="Coffey, Barbara" uniqKey="Coffey B" first="Barbara" last="Coffey">Barbara Coffey</name><name sortKey="Coffey, Barbara" sort="Coffey, Barbara" uniqKey="Coffey B" first="Barbara" last="Coffey">Barbara Coffey</name><name sortKey="Crespi, Giovanna" sort="Crespi, Giovanna" uniqKey="Crespi G" first="Giovanna" last="Crespi">Giovanna Crespi</name><name sortKey="Koval, Stephen" sort="Koval, Stephen" uniqKey="Koval S" first="Stephen" last="Koval">Stephen Koval</name><name sortKey="Kurlan, Roger" sort="Kurlan, Roger" uniqKey="Kurlan R" first="Roger" last="Kurlan">Roger Kurlan</name></country><country name="Allemagne"><region name="Basse-Saxe"><name sortKey="Mueller Ahl, Kirsten" sort="Mueller Ahl, Kirsten" uniqKey="Mueller Ahl K" first="Kirsten" last="Mueller-Vahl">Kirsten Mueller-Vahl</name></region></country><country name="Canada"><noRegion><name sortKey="Wunderlich, Glen" sort="Wunderlich, Glen" uniqKey="Wunderlich G" first="Glen" last="Wunderlich">Glen Wunderlich</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001476 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001476 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:563328031B9EB7FF732D960D9842281AACFC3197
|texte= A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome
}}
| This area was generated with Dilib version V0.6.29. |  |